(Q48799793)

15 February 2018

title

Insulin to treat Alzheimer's disease: just follow your nose? (English)

1 reference

15 February 2018

0 references

1 reference

4

1 reference

15 February 2018

Samantha J Brooks

object named as

Samantha J Brooks

series ordinal

3

0 references

Helgi B. Schiöth

series ordinal

1

object named as

Helgi B Schiöth

1 reference

15 February 2018

William H Frey

2

1 reference

15 February 2018

language of work or name

English

0 references

publication date

1 January 2012

1 reference

15 February 2018

Expert Review of Clinical Pharmacology

published in

1 reference

15 February 2018

volume

5

1 reference

15 February 2018

issue

1

1 reference

15 February 2018

page(s)

17-20

1 reference

15 February 2018

Recent patents review on intranasal administration for CNS drug delivery

cites work

1 reference

Transcortical direct current potential shift reflects immediate signaling of systemic insulin to the human brain

21 January 2018

1 reference

Epidemiology of Alzheimer disease

21 January 2018

1 reference

Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease

21 January 2018

1 reference

Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders?

21 January 2018

1 reference

Alzheimer's disease is type 3 diabetes-evidence reviewed

21 January 2018

1 reference

FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease

21 January 2018

1 reference

Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype.

21 January 2018

1 reference

Intranasal insulin improves memory in humans

21 January 2018

1 reference

Intranasal insulin improves memory in humans: superiority of insulin aspart.

21 January 2018

1 reference

Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin

21 January 2018

1 reference

Intranasal insulin as a therapeutic option in the treatment of cognitive impairments

21 January 2018

1 reference

Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative

21 January 2018

1 reference

Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype

21 January 2018

1 reference

Intranasal insulin improves cognition and modulates beta-amyloid in early AD.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ECP.11.70

1 reference

15 February 2018

release_hbnpiyodvjbmrl6hkdvs6bvcvy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hbnpiyodvjbmrl6hkdvs6bvcvy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

15 February 2018